+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Photoradiation methods for purging autologous bone marrow grafts



Photoradiation methods for purging autologous bone marrow grafts



Progress in Clinical and Biological Research 333: 87-102



The potential of various photoradiation therapy for the in vitro purging of residual tumor cells from autologous bone marrow (BM) transplants is discussed in this paper. The results with fluorescent dyes, Dihematoporphyrin Ether (DHE) and Merocyanine-540 (MC-540) are detailed. Following photoradiation of cells with white light, both DHE and MC-540 showed high cytocidal activity towards lymphoid and myeloid neoplastic cells, but had significantly less effect on normal granulocyte-macrophage (CFU-GM), erythroid (BFU-E) and mixed colony-forming (CFU-GEMM) progenitor cells. Acute promyelocytic leukemia (HL-60), non-B, non-T, cALLa positive acute lymphoblastic leukemia (Reh), and diffuse histiocytic B-cell lymphoma (SK-DHL-2) cell lines were exposed to different drug concentrations in combination with white light at a constant illumination rate of 50,000 lux. With DHE doses varying from 2.0 to 2.5 ug/ml and MC-540 concentrations of 15 to 20 ug/ml, clonogenic tumor cells could be reduced by more than 4 logs, when treated alone or in mixtures with normal irradiated human marrow cells. However, preferential cytotoxicity towards neoplastic cells was highly dependent on the mode of light activation. MC-540 had no substantial effect on malignant lymphoid (SK-DHL-2) and myeloid (HL-60) cells, and on normal marrow myeloid (CFU-GM) precursors, when the drug incubation was performed in the dark and followed by light exposure of washed cells. Equal doses of MC-540 (15-20 ug/ml) could preferentially eliminate tumor cells under conditions of simultaneous light and drug treatment (30 minutes at 37 degrees C). Using DHE (2.5 ug/ml), 29.3%, 46.8%, and 27.5% of normal marrow CFU-GM, BFU-E, and CFU-GEMM, respectively, were spared, following sequential drug and light exposure of cells, while simultaneous treatment reduced both normal (CFU-GM) and neoplastic cells below the limits of detection. The data from various centers is briefly discussed with special emphasis on clinical trials. Our results provide a useful model for leukemia and lymphoma cells and suggest that these phototherapy experiments can be implemented into clinical trials.

(PDF emailed within 1 workday: $29.90)

Accession: 040973620

Download citation: RISBibTeXText

PMID: 2137934


Related references

Breast cancer and laser photoradiation therapy: an in vitro model for autologous bone marrow purging. Progress in Clinical and Biological Research 333: 103-107, 1990

Elimination of clonogenic tumor cells from HL-60, Daudi, and U-937 cell lines by laser photoradiation therapy: implications for autologous bone marrow purging. Blood 73(4): 1059-1065, 1989

A two-phase approach to B lymphocyte purging of autologous bone marrow grafts for patients with malignant lymphoma contaminated bone marrow. Progress in Clinical and Biological Research 389: 105-109, 1994

Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts. Blood 70(2): 484-489, 1987

Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma. Progress in Clinical and Biological Research 377: 71-78, 1992

Evaluation of parameters for purging of autologous bone marrow grafts with 4 hydroperoxycyclophosphamide. Bone Marrow Transplantation 2(SUPPL 2): 147-148, 1987

Immunomagnetic purging of bone marrow grafts for autologous transplantation in neuroblastoma. Acta Clinica Belgica 45(2): 97-106, 1990

Density-gradient separation for 4-hydroperoxycyclophosphamide purging of autologous bone marrow grafts. Progress in Clinical and Biological Research 333: 369-377, 1990

Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts. Experimental Hematology 25(7): 629-637, 1997

A study of two alternative purging methods utilizing positive selection of stem cells or negative purging with vincristine , V-16, and verapamil in autologous bone marrow transplant for advanced neuroblastoma. Blood 84(10 SUPPL 1): 721A, 1994

Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts. Progress in Clinical and Biological Research 389: 147-154, 1994

Density gradient separation of autologous bone marrow grafts before ex vivo purging with 4 hydroperoxycyclosphosphamide. Bone Marrow Transplantation 6(5): 321-328, 1990

Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia. Journal of HematoTherapy 6(5): 495-500, 1997

Purging of autologous bone marrow grafts in children with high-risk neuroblastoma by temporary iron removal. Pediatric Research 37(4 PART 2): 165A, 1994